| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.08 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |